DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $30,186,000 | +13.2% | 1,300,000 | 0.0% | 2.31% | +16.7% |
| Q1 2024 | $26,676,000 | -4.4% | 1,300,000 | 0.0% | 1.98% | -27.6% |
| Q4 2023 | $27,898,000 | +4.0% | 1,300,000 | 0.0% | 2.74% | -7.7% |
| Q3 2023 | $26,819,000 | -30.1% | 1,300,000 | 0.0% | 2.97% | -11.5% |
| Q2 2023 | $38,363,000 | +28.1% | 1,300,000 | 0.0% | 3.35% | +35.9% |
| Q1 2023 | $29,952,000 | -17.2% | 1,300,000 | 0.0% | 2.47% | -11.9% |
| Q4 2022 | $36,153,000 | +18.4% | 1,300,000 | +30.7% | 2.80% | +39.6% |
| Q3 2022 | $30,537,000 | -30.8% | 995,000 | -33.7% | 2.01% | -46.3% |
| Q2 2022 | $44,145,000 | -8.5% | 1,500,000 | 0.0% | 3.73% | +72.5% |
| Q1 2022 | $48,255,000 | -27.9% | 1,500,000 | 0.0% | 2.16% | +14.7% |
| Q4 2021 | $66,900,000 | -22.0% | 1,500,000 | -11.8% | 1.89% | -11.7% |
| Q3 2021 | $85,765,000 | -32.1% | 1,700,000 | +5.6% | 2.14% | -33.4% |
| Q2 2021 | $126,288,000 | +37.4% | 1,610,000 | 0.0% | 3.21% | +17.1% |
| Q1 2021 | $91,931,000 | -16.2% | 1,610,000 | +22.9% | 2.74% | -15.8% |
| Q4 2020 | $109,726,000 | +133.8% | 1,310,000 | 0.0% | 3.25% | +54.7% |
| Q3 2020 | $46,937,000 | +48.2% | 1,310,000 | 0.0% | 2.10% | +12.1% |
| Q2 2020 | $31,676,000 | +24.3% | 1,310,000 | -10.0% | 1.88% | -30.7% |
| Q1 2020 | $25,477,000 | +17.0% | 1,455,000 | +16.4% | 2.70% | +35.1% |
| Q4 2019 | $21,775,000 | -99.8% | 1,250,000 | +92.3% | 2.00% | +94.2% |
| Q3 2019 | $9,958,000,000 | +19.9% | 650,000 | +62.5% | 1.03% | +32.7% |
| Q2 2019 | $8,304,000,000 | +357522.7% | 400,000 | +300.0% | 0.78% | +204.7% |
| Q1 2019 | $2,322,000 | +12.4% | 100,000 | 0.0% | 0.26% | -27.8% |
| Q4 2018 | $2,066,000 | – | 100,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |